July 21, 2016 / 12:22 PM / in a year

BRIEF-RepliCel therapy for pattern baldness proceeds to clinical trial launch in Japan

July 21 (Reuters) - RepliCel Life Sciences Inc :

* RCH-01 product cleared by Japanese regulatory authorities for use in clinical research study launching now in Japan

* Study financed by Shiseido company, each product being injected to be manufactured by Shiseido at facility in Kobe, Japan

* Replicel’s cell therapy for pattern baldness proceeds to clinical trial launch in Japan Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below